Results for “ ”

Entry Author Date Location
Nimbus’s LLC Origins Pay off As Gilead Shells Out $400M For Liver Drug 04/04/16 Boston
At Long Last, First Drug Approval in Sight for Amicus 04/01/16 New York
East Coast Biotech Roundup: NY Disruptors, Commense, Regeneron, & More 04/01/16 Boston
What’s Ahead for Biotech in 2016: Q&A With BIO Chair Ron Cohen 03/31/16 New York
New PureTech Startup Commense Aims to Protect Babies From Disease 03/31/16 Boston
“Raw Potential” And Three Other Takeaways from NY’s Life Science Disruptors 03/30/16 New York
With New Execs, Sanofi Backing, ImmuneXcite Begins Clinical Push 03/30/16 Boston
The Xconversation: Vaccine Developer Meets Energy Innovator, Part II 03/30/16 Seattle
The Xconversation: Vaccine Developer Meets Energy Innovator, Part I 03/29/16 Seattle
With New Data, Alder Keeps Pace in Migraine Drug Race 03/28/16 Seattle
Emulate Gets $28M to Roll Out “Plug and Play” Organ-on-Chip Tech 03/28/16 Boston
Restructuring Looms for Forum as Neuro Drug Fails Key Clinical Test 03/24/16 Boston
Gerngross, Singer Join “What’s Hot in Boston Biotech” on April 6 03/24/16 Boston
East Coast Biotech Roundup: Harvard’s Haul, Patent Fights, Padlock & More 03/24/16 Boston
CRISPR And Beyond: UCSD-Doudna Work Attracts Paul Allen’s Millions 03/23/16 National
Quanterix Expands in Diagnostics With $46M in New Cash 03/23/16 Boston
Tarveda Formally Spins Out Placon to Advance Platinum Cancer Drugs 03/23/16 Boston
Gilman Scores for Atlas Again as Bristol Buys Padlock for up to $600M 03/23/16 Boston
NY Bio Startup Syntimmune Gets $10M From Baxalta, Apple Tree 03/22/16 New York
BioMarin Heads to FDA With Mixed Data For Rare Disease Drug 03/21/16 San Francisco
Maxwell Health Gets $22M More to Simplify Health Benefits 03/21/16 Boston
Tech Megatransfer: Merck Pays Harvard $20M For “Accelerated” Cancer Drugs 03/21/16 Boston
East Coast Bio Roundup: PCSK9 Battle, NYU Startups, Blueprint & More 03/17/16 Boston
Saver Rate Ends Today for What’s Hot in Boston Biotech 03/17/16 Boston
Blueprint, Roche Ink Milestone Deal for Cancer Immunotherapy 03/15/16 Boston
Procrastinator’s Special Ends Today for NY’s Life Science Disruptors 03/15/16 New York
Racing Zika: For Every Short Cut, There’s An Open Question 03/15/16 National
Hear Lew Cantley, Others on Shaping NY Biotech on March 29 03/11/16 New York
Failed Alzheimer’s Drug To Get Another Shot, If Investors Pony Up 03/11/16 Boston
What’s Hot in Boston Biotech: Here’s the Agenda 03/10/16 Boston
Page 2 of 280 « previous page · next page »